Tag: Prescription Drugs
FDA Safety Announcement Affected Bisphosphonate Use
Four percent decrease in odds of bisphosphonate use each quarter after safety announcement for a-fib risk
Many A-Fib Patients Missing Out on Recommended Anticoagulation
Less than half at highest risk take recommended anticoagulants
Off-Label Use of Metformin Common in U.S. Adolescents
Analyses of three databases show use for metabolic syndrome, PCOS, and obesity
CDC Issues New Prescription Guidelines for Opioids
To curb abuse, doctors should try non-opioid options for chronic pain not involving cancer, terminal illness
Antihyperglycemic Medication Prescribing Trends Are Changing
Decrease in glyburide and thiazolidinedione Rx; increase in gliclazide, dipeptidyl peptidase-4 inhibitor
Antioxidant-Pregabalin Cuts Pain in Chronic Calcific Pancreatitis
Randomized trial shows significant pain reduction for patients with chronic calcific pancreatitis
Analgesics Plus Exercise Therapy Feasible for Knee OA
Seventy-eight percent of patients could participate in exercise protocol after analgesic use
Rebound Growth for One in Four With Infantile Hemangioma
Factors linked to rebound growth include age of discontinuation, deep IH, and female gender
Warfarin’s Intracranial Bleed Risk Higher Than Previously Reported
Several factors place patients at increased risk of traumatic intracranial bleeding
Combo Tx Protects Pregnant Women, Fetuses From Malaria
Findings suggest older medication is losing effectiveness, researchers say
